Serine/Threonine Protein Kinase Pim 3 - Pipeline Review, H2 2020

Published	Pages	Publisher	Report code
Jul 2020	45	Global Markets Direct	ASDR-559179

Published: Jul 2020 - Pages : 45 - Publisher : Global Markets Direct - Report code : ASDR-559179

Incyte Corp
Inflection Biosciences Ltd
NewBay Medical Technology Co Ltd
Novartis AG
Onconova Therapeutics Inc
Tolero Pharmaceuticals Inc
Yakult Honsha Co Ltd

Serine/Threonine Protein Kinase Pim 3 (Pim 3 Oncogene or PIM3 or EC 2.7.11.1) - Drugs in Development, 2021

This report can be of interest as well:

Serine/Threonine Protein Kinase Pim 3 (Pim 3 Oncogene or PIM3 or EC 2.7.11.1) - Drugs in Development, 2021

Published: March, 2021 | Report code: ASDR-577309